pyrazines has been researched along with Cardiomyopathy, Dilated in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, D; Chen, S; Hollander, SA; Kaufman, BD; Maeda, K; May, LJ; Rosenthal, DN; Tyan, DB; Yeh, J | 1 |
| Lü, D; Ma, CM; Qin, C; Wang, SM; Zhang, L; Zhang, LF; Zhang, W; Zhao, HP | 1 |
| Ge, WP; Liu, N; Lu, D; Ma, CM; Qin, C; Shao, HT; Zhang, LF; Zhang, X | 1 |
| Fowler, MB; Keu, KV; Quon, A; Tavana, H; Witteles, RM | 1 |
| Airaksinen, KE; Engblom, E; Hesse, B; Iozzo, P; Knuuti, J; Någren, K; Naum, A; Nuutila, P; Opie, LH; Tuunanen, H; Ukkonen, H | 1 |
| Bertolet, BD; Pepine, CJ; White, BG | 1 |
| Moore, CK; O'Connell, JB; Waterer, HC | 1 |
| Matsumori, A; Sasayama, S | 1 |
| Matsumori, A | 1 |
| Kurabayashi, M; Yamaoki, K; Yazaki, Y | 1 |
| Baughman, KL; Becker, LC; Feldman, AM; Gottlieb, SH; Lee, WK; Strobeck, JE; Weiss, JL | 1 |
| Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S | 1 |
| Baughman, KL; Becker, LC; Feldman, AM; Llewellyn, MP | 1 |
| Asanoi, H; Hori, M; Inoue, M; Kawai, C; Kodama, K; Sakurai, T; Sasayama, S | 1 |
4 review(s) available for pyrazines and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Treatment of end stage dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Transplantation; Humans; Pyrazines; Quinolines; Vasodilator Agents | 1994 |
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomyopathy, Dilated; Cardiotonic Agents; Cardiovirus Infections; Cytokines; Encephalomyocarditis virus; Heart Failure; Humans; Mice; Myocarditis; Prodrugs; Pyrazines; Quinolines; Tetrazoles; Tumor Necrosis Factor-alpha | 1995 |
Cytokines in myocarditis and cardiomyopathies.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cytokines; Heart Injuries; Hepatitis C; Humans; Mice; Mice, Mutant Strains; Myocarditis; Pyrazines; Quinolines | 1996 |
[Dilated cardiomyopathy in children].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Child, Preschool; Humans; Infant; Prognosis; Pyrazines; Quinolines | 1996 |
3 trial(s) available for pyrazines and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.
Topics: Aged; Cardiac Output, Low; Cardiomyopathy, Dilated; Coronary Circulation; Echocardiography; Fatty Acids, Nonesterified; Female; Heart; Heart Rate; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardium; Oxidation-Reduction; Positron-Emission Tomography; Pyrazines; Ventricular Function, Left | 2006 |
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Pyrazines; Quality of Life; Quinolines | 1991 |
Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Trials as Topic; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pyrazines; Quinolines; Respiratory Function Tests | 1988 |
7 other study(ies) available for pyrazines and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
HLA desensitization with bortezomib in a highly sensitized pediatric patient.
Topics: Antibodies, Monoclonal, Murine-Derived; Boronic Acids; Bortezomib; Cardiomyopathy, Dilated; Child; Combined Modality Therapy; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; HLA Antigens; Humans; Immunologic Factors; Isoantibodies; Male; Plasmapheresis; Proteasome Inhibitors; Pyrazines; Rituximab; Transplantation Conditioning | 2014 |
Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic mice.
Topics: Animals; Cadherins; Cardiomyopathy, Dilated; Echocardiography; Heart; Humans; Hypertrophy; Ligusticum; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Muscle Proteins; Mutation; Myocardium; Platelet Aggregation Inhibitors; Pyrazines; Troponin T | 2010 |
Ginsenoside-Rb1 and tetramethylpyrazine phosphate act synergistically to prevent dilated cardiomyopathy in cTnTR141W transgenic mice.
Topics: Animals; Blotting, Western; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Cardiomyopathy, Dilated; Disease Models, Animal; Disease Progression; Drug Synergism; Drug Therapy, Combination; Echocardiography; Gene Expression Regulation; Ginsenosides; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy.
Topics: Adult; Blood Glucose; Cardiomyopathy, Dilated; Dipeptidyl-Peptidase IV Inhibitors; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Male; Middle Aged; Myocardium; Pyrazines; Sitagliptin Phosphate; Statistics as Topic; Statistics, Nonparametric; Triazoles | 2012 |
Neutropenia occurring during treatment with vesnarinone (OPC-8212).
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Trials as Topic; Europe; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Male; Middle Aged; Neutropenia; Pyrazines; Quinolines; Risk Factors; Time Factors; United States | 1994 |
[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Cardiotonic Agents; Circadian Rhythm; Digitalis; Drug Evaluation; Electrocardiography, Ambulatory; Ethanolamines; Female; Heart Rate; Humans; Male; Middle Aged; Plants, Medicinal; Plants, Toxic; Propanolamines; Pyrazines; Quinolines; Xamoterol | 1990 |
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocarditis; Pyrazines; Quinolines | 1986 |